Comment on “Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cirrhotic Patients with Acute-on-Chronic Liver Failure”

References (1)

1. Chiriac S, Stanciu C, Singeap AM, Sfarti CV, Cuciureanu T, Trifan A. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure. Turk J Gastroenterol. 2020;31(12):868-876. [CrossRef] 2. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-37, 1437.e1. [CrossRef] 3. Silva PE, Fayad L, Lazzarotto C, et al. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis. Liver Int. 2015;35(5):1516-1523. [CrossRef] 4. Agbim U, Sharma A, Maliakkal B, et al. Outcomes of liver transplant recipients with acute-on-chronic liver failure based on EASLCLIF consortium definition: a single-center study. Transplant Direct. 2020;6(4):e544. [CrossRef] 5. Wu W, Yan H, Zhao H, et al. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: differentiate it from No-ACLF. Liver Int. 2018;38(2):248-257. [CrossRef]